Small intestine morphology and recovery after drug-induced colitis in proglucagon-derived peptides knockout mice
نویسندگان
چکیده
Objective. Dipeptidyl peptidase (DPP)-4 inhibitors inactivate glucagonlike peptide (GLP)-1, GLP-2, and other hormones by degradation. Administration of a DPP-4 inhibitor or GLP-2 analog stimulates intestinal growth and facilitates the restoration of mucosal damage caused by drug-induced colitis in mice. We studied the effect of GLP-2 deletion on morphological changes on gut and colitis recovery in mice deficient in proglucagon-derived peptides (PGDPs). Material and methods. Mice deficient in PGDPs were used. Eight-week-old male PGDPs−/− and PGDPs+/+ mice were sacrificed to examine the small intestine and colon morphology. To elucidate the effect of PGDP deletion on colitis, 12-week-old PGDPs−/− and PGDPs+/+ male mice were exposed to 2.5% dextran sulfate sodium (DSS) for 6 days. Colitis severity was assessed daily by disease activity index and body weight loss. Histological examinations were performed on days 7 and 21. Results. There were no differences in the height, width, and density of villous and the depth of crypt of small intestine, and the weight, length, and the crypt depth of colon between PGDPs−/− and PGDPs+/+. In DSS colitis, the decline and amelioration of disease activity index and body weight were not different between the PGDP−/− and PGDP+/+ mice. Histologically, the PGDP−/− mice showed significantly less recovery than showed by the PGDPs+/+ mice on day 21 (p < 0.05). Conclusion. Mice with PGDP deletion did not show morphological changes of gut. On colitis, PGDP deletion only caused less histological amelioration of colitis in the later phase of recovery. Subjects: Gastroenterology; Hepatology; Medicine
منابع مشابه
Effects of capsaicin in low doses and high doses on the small intestine motor response in wild-type and TRPV1 knockout mice
متن کامل
Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells
AIMS/HYPOTHESIS Glucagon-like peptide-1 (GLP-1) is an incretin hormone derived from proglucagon, which is released from intestinal L-cells and increases insulin secretion in a glucose dependent manner. GPR119 is a lipid derivative receptor present in L-cells, believed to play a role in the detection of dietary fat. This study aimed to characterize the responses of primary murine L-cells to GPR1...
متن کاملBiological actions and therapeutic potential of the glucagon-like peptides.
The glucagon-like peptides (GLP-1 and GLP-2) are proglucagon-derived peptides cosecreted from gut endocrine cells in response to nutrient ingestion. GLP-1 acts as an incretin to lower blood glucose via stimulation of insulin secretion from islet beta cells. GLP-1 also exerts actions independent of insulin secretion, including inhibition of gastric emptying and acid secretion, reduction in food ...
متن کاملPPARβ/δ activation induces enteroendocrine L cell GLP-1 production.
BACKGROUND & AIMS Glucagon-like peptide (GLP)-1, an intestinal incretin produced by L cells through proglucagon processing, is secreted after nutrient ingestion and acts on endocrine pancreas beta cells to enhance insulin secretion. Peroxisome proliferator-activated receptor (PPAR) β/δ is a nuclear receptor that improves glucose homeostasis and pancreas islet function in diabetic animal models....
متن کاملEffect of the essential oil of thyme on intestinal morphology in Rat
Background & Aim: Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in clinical medicine. The adverse effects they produce in the gastrointestinal tract however, often limit their utility. Oxidative stress has been shown to occur in the small intestine in response to the oral administration of indomethacin. In view of this, the effect of thyme essential oil, an agent with anti-o...
متن کامل